AEON (AEON Biopharma, Inc.) Stock Analysis - Analyst Ratings

AEON Biopharma, Inc. (AEON) is a publicly traded Healthcare sector company. As of May 21, 2026, AEON trades at $0.86 with a market cap of $22.49M and a P/E ratio of -0.22. AEON moved +0.91% today. Year to date, AEON is -23.64%; over the trailing twelve months it is +69.63%. Its 52-week range spans $0.38 to $115.57. Rallies surfaces AEON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate AEON?

The average price target is $0.00.

AEON Key Metrics

Key financial metrics for AEON
MetricValue
Price$0.86
Market Cap$22.49M
P/E Ratio-0.22
EPS$-3.95
Dividend Yield0.00%
52-Week High$115.57
52-Week Low$0.38
Volume36.94K
Avg Volume0
Revenue (TTM)$0
Net Income$-39.22M
Gross Margin0.00%

AEON Analyst Consensus

AEON analyst coverage data. Average price target: $0.00.

Latest AEON News

Recent AEON Insider Trades

  • FISCHER JOST bought 60.00K (~$29.25K) on May 21, 2025.
  • FISCHER JOST bought 60.00K (~$30.36K) on May 20, 2025.
  • FISCHER JOST bought 50.00K (~$24.94K) on May 19, 2025.

Common questions about AEON

What do analysts rate AEON?
The average price target is $0.00.
Does Rallies show AEON price targets?
Yes. Rallies tracks AEON analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is AEON research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AEON. It does not provide personalized investment advice.
AEON

AEON